Chronopharmacology of Anti-Convulsive Therapy

View/ Open
Published Version
https://doi.org/10.1007/s11910-013-0339-2Metadata
Show full item recordCitation
Ramgopal, Sriram, Sigride Thome-Souza, and Tobias Loddenkemper. 2013. Chronopharmacology of anti-convulsive therapy. Current Neurology and Neuroscience Reports 13(4): 339.Abstract
Approximately one-third of patients with epilepsy continue to have seizures despite antiepileptic therapy. Many seizures occur in diurnal, sleep/wake, circadian, or even monthly patterns. The relationship between biomarkers and state changes is still being investigated, but early results suggest that some of these patterns may be related to endogenous circadian patterns whereas others may be related to wakefulness and sleep or both. Chronotherapy, the application of treatment at times of greatest seizure susceptibility, is a technique that may optimize seizure control in selected patients. It may be used in the form of differential dosing, as preparations designed to deliver sustained or pulsatile drug delivery or in the form of ‘zeitgebers’ that shift endogenous rhythms. Early trials in epilepsy suggest that chronopharmacology may provide improved seizure control compared with conventional treatment in some patients. The present article reviews chronopharmacology in the treatment of epilepsy as well as future treatment avenues.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607723/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:10627603
Collections
- HMS Scholarly Articles [17730]
Contact administrator regarding this item (to report mistakes or request changes)